Publications by authors named "Matt Minerva"

Claim this Profile
S
Safety and efficacy of once-weekly efruxifermin versus placebo in metabolic dysfunction-associated steatohepatitis (HARMONY): 96-week results from a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial.
Mazen Noureddin, Juan P Frias, Guy W Neff, K Jean Lucas, Cynthia Behling, Matt Minerva

Lancetยท August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis